Asthma clinical trials in Pennsylvania
11 studies for Asthma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Philadelphia
- Research Site, Smithfield
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06932263A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- University of Pittsburgh Medical Center, Pittsburgh
- Allergy and Clinical Immunology Associates, Pittsburgh
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07219173A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research Associates of Central PA, LLC, DuBois
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12072, Philadelphia
- Teva Investigational Site 12114, Pittsburgh
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 31, 2026 · NCT06664619A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, DuBois
- GSK Investigational Site, Wyomissing
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 17, 2026 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Pittsburgh
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Aug 13, 2026 · NCT06307665Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT04743791A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Pittsburgh
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07532265Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT06979323A Study of CDX-622 in Participants With Mild to Moderate Asthma
- University of Pittsburgh Asthma and Environmental Lung Health Institute at UPMC, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07330778Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
RecruitingHealthy volunteers welcome
Ages 8 to 70 · All sexes · Updated Oct 24, 2025 · NCT06512064From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.